Private Equity Healthcare Deals Hit $191B in 2025

TL;DR: Private equity poured a record $191 billion into healthcare in 2025, according to Bain & Company, driven by a surge in billion-dollar deals and a rebound in exits to $156 billion. The money is chasing AI-enabled healthcare IT, physician practices, and post-acute care — and the fee stack on these vehicles still eats returns before you see them.

The Biggest Healthcare Buyout Year on Record

I ran zero-failure QA on a nuclear submarine before I ever signed a term sheet. I've raised capital that worked, and capital that didn't. Healthcare just posted its biggest private equity year on record, and the firms writing the checks are telling you where they think the next decade of margin sits: AI-enabled back-office software, physician practices, and the facilities that keep aging patients out of hospitals. The roll-up plays in this cycle live or die on sponsor diligence — the same discipline I used to sign off on a work package before it ever touched a reactor. If you're an accredited investor with capital to deploy, that number should make you curious and skeptical in the same breath.

What Actually Happened in 2025

Global healthcare private equity hit an estimated $191 billion in deal value last year, surpassing the prior record set in 2021, according to Bain & Company. Deal volume held up too: investors announced 445 buyouts, the second-most on record, per the same report.

The bigger signal is on the exit side. Exit value jumped to an expected $156 billion in 2025, the second-highest ever, up from $54 billion in 2024, according to Bain, sponsor-to-sponsor deals drove the rebound. More than 30 of those deals topped $1 billion in 2025, compared with only eight in 2024, Bain found. That's the exit math finally working again after two slow years, and it's why sponsors are willing to pay up for new platforms now.

Why AI-Enabled Healthcare IT Is Pulling a Disproportionate Share

Healthcare IT deal value doubled in 2025 to roughly $32 billion, according to PitchBook data cited by the Atlanta Business Chronicle. PE-specific investment in the space reached $14.6 billion, a 595 percent jump from $2 billion in 2024, per the same reporting.

That trend kept accelerating into this year, though on a different clock than the 2025 record above: M&A targeting AI-enabled healthcare assets spiked 93.8 percent year-over-year to 62 transactions through the first half of 2026, according to Capstone Partners' September 2026 Healthcare IT Market Update, now 34.6 percent of all sector deals, up from 8.7 percent in 2022. Private equity represented 49.7 percent of all healthcare IT transaction volume in that stretch, driven by a 29.3 percent rise in add-on acquisitions: sponsors tucking VC-backed AI platforms into the electronic health record and revenue-cycle-management businesses they already own.

That's a specific strategy, not a vague AI bet: buy the EHR or billing platform first, then bolt the AI layer on as an add-on, at a lower multiple than a standalone acquisition would command.

Physician Practices and Post-Acute Care: The Roll-Up Play

The other half of this story is older and less glamorous: PE firms consolidating physician practices and post-acute facilities, home health, hospice, skilled nursing, into regional platforms. The economics are the same roll-up logic private equity has run in dental, veterinary, and dermatology for a decade. The sponsor buys the management company, keeps clinical ownership with physicians where state corporate-practice-of-medicine laws require it, and extracts margin from billing, staffing, and scale.

A live example of how this plays out: ResMed sold its MatrixCare software business, which serves nursing, senior living, and home health and hospice providers, to Frazier Healthcare Partners for $490 million in cash, 34 percent less than the $750 million ResMed paid for it in 2018, according to The West Australian. Not every exit in this cycle is a win for the seller. Multiples compress, and a strategic buyer can walk away from software it overpaid for eight years ago.

The demographic tailwind isn't subtle: roughly 10,000 baby boomers turn 65 every day, according to the Atlanta Business Chronicle. That's the demand curve sponsors are underwriting against.

2024 vs. 2025, by the Numbers

Metric	2024	2025	Source
Exit value	$54 billion	$156 billion (second-highest ever)	Bain & Company
Sponsor-to-sponsor deals over $1B	8	30+	Bain & Company
PE investment in healthcare IT	$2 billion	$14.6 billion	PitchBook, via Atlanta Business Chronicle

Two more 2025 figures stand alone because the sources behind this piece don't print a comparable 2024 number: total healthcare PE deal value hit $191 billion, a record, and sponsors announced 445 buyouts, the second-most on record, both according to Bain & Company. AI-enabled M&A's 34.6 percent share of sector deals is a separate, more recent data point, measured through the first half of 2026, don't read it as one continuous line with the 2025 figures above.

What Does This Mean If You Can't Write a $250 Million Check?

Most of the $191 billion moved between institutions you'll never meet, inside funds the typical accredited investor can't access directly. The trend is real; be precise about how you get exposure to it. Publicly traded healthcare-focused BDCs and listed private equity managers give you a liquid, if diluted, read on this cycle without a capital call. A feeder fund or interval fund marketed as "healthcare PE access" is a different animal: read the fee stack before the pitch, because a layer of fees sits between you and every dollar Bain just reported.

Downside first: healthcare roll-ups carry regulatory risk, state corporate-practice-of-medicine enforcement, Stark Law and anti-kickback exposure, that a generic industrials roll-up doesn't. The sponsor's track record on prior physician-practice platforms, not the AI story in the pitch deck, is what you verify before you trust. Before you commit capital, compare the pitch against what realized returns in this asset class actually look like rather than the projected number in the deck.

Common Mistakes

• Treating a record deal-value year as a signal to buy in now. A record year means capital already moved. It doesn't tell you what you'll pay to get exposure today.
• Assuming AI-enabled healthcare IT means a differentiated return. Capstone's own data shows this is mostly add-on consolidation into EHR and billing platforms sponsors already own, bolt-on economics, not a new category.
• Confusing a listed BDC or healthcare-adjacent public stock with direct private equity access. They correlate loosely with the cycle. They are not the same investment.
• Skipping the exit math. Exit value bounced back to $156 billion in 2025 after a two-year slump, that recovery, not the headline deal value, is what makes new capital willing to come in behind it.

FAQ

What are the biggest private equity firms in healthcare? Today's reporting doesn't rank firms by size, so I won't invent a list. What's confirmed: Frazier Healthcare Partners was the buyer in the ResMed/MatrixCare deal, one of 2026's named healthcare-services transactions, a specialist, not a generalist mega-fund.

What happens when private equity buys a medical practice? The PE firm typically buys the management services organization, billing, staffing, real estate, back office, while physicians retain clinical ownership where state corporate-practice-of-medicine law requires it. The firm then rolls up several practices into one regional platform to sell at a higher multiple later.

Which PE firm owns the most hospitals? No sourced ranking of hospital ownership by PE firm appears in today's reporting. Hospital ownership structures are often layered through management companies, and that opacity is itself worth noting before you assume you know who's behind a facility.

What percentage of US hospitals are owned by private equity? That specific figure isn't in the sources behind this piece, so I'm not printing a number I can't source. What is sourced: 2025 set a record for healthcare PE deal value, and the second-highest buyout count on record. The trend is accelerating, even without a precise penetration figure.

One Thing to Do Today

If a sponsor pitches you healthcare-sector exposure off this report, ask for the fund's realized exits from its last physician-practice or healthcare-IT platform, not its projected IRR on the new one. Want the next one of these flagged before the fee stack catches up? That's what the free AIN newsletter is for.

Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.